Sexcord/ stromal ovarian tumors screening

Sexcord/ stromal ovarian tumors Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Sexcord/ Stromal Ovarian Tumors from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Sexcord/ stromal ovarian tumors screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Sexcord/ stromal ovarian tumors screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Sexcord/ stromal ovarian tumors screening
CDC on Sexcord/ stromal ovarian tumors screening
Sexcord/ stromal ovarian tumors screening in the news
Blogs on Sexcord/ stromal ovarian tumors screening
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Sexcord/ stromal ovarian tumors screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

The US Preventive Services Task Force(USPSTF) recommends against screening for ovarian cancer in asymptomatic women